Skip to main content
. 2022 Jul 5;157:116725. doi: 10.1016/j.trac.2022.116725

Fig. 3.

Fig. 3

(A) Schematic representation of the LFIA test for the diagnosis of SARS CoV-2. Antibodies; (B) For the negative sample, only the control line color is expected; (C) 2 test regions and 1 control regions appear in the asset of anti-N antibodies (IgG, IgM and IgA) [53]. Reproduced with permission from ref. 53, Elsevier Ltd.